Septerna updates corporate presentation for investor meetings; no material new data disclosed

Septerna, Inc.

Updated corporate presentation dated September 2025 for use with investors and analysts.
Presentation focuses on Septerna's GPCR drug discovery platform.
No financial results, clinical data, or guidance changes were announced in the filing.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.